Yuan Shuo, Wang Qi, Li Jiao, Xue Jia-Chen, Li You, Meng Huan, Hou Xiao-Ting, Nan Ji-Xing, Zhang Qing-Gao
Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, 133002, Jilin, China.
Chronic Disease Research Center, Medical College, Dalian University, Dalian, 116622, Liaoning, China.
Chin Med. 2022 Jun 18;17(1):74. doi: 10.1186/s13020-022-00633-4.
Inflammatory bowel disease (IBD) is a chronic recurrent inflammatory disease of the intestine, including Crohn's disease (CD) and ulcerative colitis (UC), whose etiology and pathogenesis have not been fully understood. Due to its prolonged course and chronic recurrence, IBD imposes a heavy economic burden and psychological stress on patients. Traditional Chinese Herbal Medicine has unique advantages in IBD treatment because of its symptomatic treatment. However, the advantages of the Chinese Herbal Medicine Formula (CHMF) have rarely been discussed. In recent years, many scholars have conducted fundamental studies on CHMF to delay IBD from different perspectives and found that CHMF may help maintain intestinal integrity, reduce inflammation, and decrease oxidative stress, thus playing a positive role in the treatment of IBD. Therefore, this review focuses on the mechanisms associated with CHMF in IBD treatment. CHMF has apparent advantages. In addition to the exact composition and controlled quality of modern drugs, it also has multi-component and multi-target synergistic effects. CHMF has good prospects in the treatment of IBD, but its multi-agent composition and wide range of targets exacerbate the difficulty of studying its treatment of IBD. Future research on CHMF-related mechanisms is needed to achieve better efficacy.
炎症性肠病(IBD)是一种肠道慢性复发性炎症性疾病,包括克罗恩病(CD)和溃疡性结肠炎(UC),其病因和发病机制尚未完全明确。由于病程迁延且慢性复发,IBD给患者带来了沉重的经济负担和心理压力。中药在IBD治疗中具有独特优势,因其能对症治疗。然而,中药复方(CHMF)的优势却鲜有探讨。近年来,许多学者从不同角度对CHMF延缓IBD进行了基础研究,发现CHMF可能有助于维持肠道完整性、减轻炎症并降低氧化应激,从而在IBD治疗中发挥积极作用。因此,本综述聚焦于CHMF治疗IBD的相关机制。CHMF具有明显优势。除了具备现代药物精确的成分和可控的质量外,它还具有多成分、多靶点的协同作用。CHMF在IBD治疗中具有良好前景,但其多药组成和广泛的靶点增加了研究其治疗IBD的难度。未来需要对CHMF相关机制进行研究以获得更好的疗效。